The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of single doses of RN0361 in Adult healthy subjects and Adult Hypertriglyceridemic Subjects.

Study of RN0361in Adult Healthy Subjects and Adult Hypertriglyceridemic Subjects

A Phase 1, Randomized, Placebo-controlled, Single Ascending Dose and Phase 2 Randomized, Placebo Controlled, Parallel-Group, Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamic Effects, and Immunogenicity of RN0361 in Adult Healthy Subjects and Hypertriglyceridemic Subjects

Clinical Trial Results for Familial Chylomicronemia Syndrome

Focus your search

Study of RN0361in Adult Healthy Subjects and Adult Hypertriglyceridemic Subjects

Description

Conditions